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Abstract 
Hormones that elevate cytosolic Ca 2+ concentrations ([Ca2+]cyt) often use Ca 2+ as a messenger to activate intramitochondrial 
metabolic processes. However, the mitochondrial Ca 2+ level also regulates the activation of the mitochondrial permeability ransition 
(MPT), a process that involves the assembly of a high conductance proteinaceous pore across the inner and outer membrane. Studies on 
intact liver cells indicate that the MPT is a critical step in the cell killing induced by anoxia or respiratory inhibitors. In this study, we 
used freshly isolated hepatocytes to investigate o what extent he elevation of [Ca2+]cy t by vasopressin or other agonists causes Ca 2÷ 
accumulation in the mitochondria and how this treatment affects the mitochondrial susceptibility to undergo the MPT. Hepatocytes were 
incubated with vasopressin, glucagon, or with thapsigargin (an inhibitor of the endoplasmic reticulum Ca 2 + pump) prior to permeabiliza- 
tion with digitonin. Mitochondrial Ca 2 ÷ accumulation was determined by following the ionomycin-induced Ca 2-- release in permeabi- 
lized cells and mitochondrial swelling was studied by following cyclosporin A-sensitive light scattering changes induced by phenyl- 
arsenoxide and rotenone. The results indicate that agents that elevate [Ca2+]cyt cause a significant Ca 2+ accumulation i the 
mitochondria. Excessive Ca 2 ÷ accumulation (> 10-fold increase over basal evels) was obtained with the combination of vasopressin and 
glucagon or with incubations containing thapsigargin. These conditions were also associated with a marked increase in rotenone-induced 
mitochondrial swelling. However, the more modest increase in mitochondrial Ca 2÷ content after treating cells with vasopressin alone did 
not enhance the swelling response; instead, vasopressin suppressed mitochondrial swelling compared to control incubations. Vasopressin 
also partly suppressed the swelling associated with thapsigargin treatment, although it did not significantly affect the Ca 2+ accumulation 
under these conditions. This effect of vasopressin was mimicked by phorbol ester, suggesting a role for protein kinase C. The data 
indicate that mitochondrial Ca 2÷ accumulation following elevation of [Ca 2+ ]cyt enhances the susceptibility for activation of the MPT, a 
response that may increase cell injury during anoxia or in response to other challenges. However, hormones also activate protective 
responses in the cell that suppress the MPT. 
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1. Introduct ion 
1.1. Ca 2 +-dependent signalling in intact liver cells 
Hormones, growth factors and other agonists that acti- 
vate the inositol ipid-dependent signal transduction system 
cause an increase in cytosolic free Ca 2+ concentration 
Abbreviations: [Ca 2+ ]cyt, cytosolic Ca 2+ concentration; CyA, cy- 
closporin A; ER, endoplasmic reticulum; InsP 3, inositol 1,4,5-tri- 
sphosphate; K-Pi, KH2PO4; MPT, mitochondrial permeability transition; 
PhAsO, phenylarsenoxide; BSA, bovine serum albumin; TPA, 12-O-tetra- 
decanoyl-4/3-phorbol- 13 acetate. 
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([Ca 2+ ]cyt) 2 in a wide variety of cell types, including liver 
cells (reviewed in [1,2]). [Ca2+]~y t is in the order of 
100-200 nM in the basal state and increases upon stimula- 
tion to concentrations ranging from 500 nM to > 1 /zM 
(there is considerable c ll-to-cell variation in these parame- 
ters). This increase in [Ca2+]cyt is due to the release of 
Ca 2+ from intracellular storage sites in the endoplasmic 
reticulum in response to the formation of inositol 1,4,5- 
trisphosphate (InsP 3) as a second messenger; in addition, 
the elevated [Ca2+]cy t is maintained by the activation of 
Ca 2+ influx into the cell through Ca 2+ channels in the 
plasma membrane. 
As first demonstrated by Cobbold and coworkers [3] in 
isolated liver cells, the elevation of cytosolic Ca 2+ levels 
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often has the character of an oscillatory response, where 
the frequency of oscillation in an individual cell is a 
function of the agonist concentration (frequency modula- 
tion), but the amplitude is relatively invariant. In addition, 
the elevation of [Ca 2÷ ]cyt is spatially heterogeneous, mov- 
ing as a wave across the cytosol of individual cells [4]. The 
mechanisms underlying the temporal and spatial hetero- 
geneity are incompletely understood, but may rely on 
Ca2÷-dependent feedback loops involving the InsP 3 recep- 
tors in the endoplasmic reticulum, in combination with an 
active reuptake of Ca 2+ in the endoplasmic reticulum 
mediated by the ATP-driven Ca 2÷ pump [2,5]. Inhibition 
of Ca 2+ reuptake into the ER with the Ca 2+ pump in- 
hibitor thapsigargin promotes a sustained elevation of 
[Ca2+]cyt, but the peak [CaZ+]cyt in individual cells after 
thapsigargin treatment is not significantly different from 
that obtained at the peak of hormone-induced Ca2 + tran- 
sients [2,4]. 
The elevation of [Ca2+]cyt causes the activation of 
multiple Ca2+-dependent enzyme systems in the cytosol, 
including CaZ+-dependent protein kinases that activate a 
variety of metabolic responses. Although many of the 
target enzymes of Ca 2+ are located in the cytosol, there is 
strong evidence that Ca 2+ also functions as a signal to 
transfer the hormonal message to the mitochondrial com- 
partment, after uptake of Ca 2+ into the mitochondrial 
matrix. Fig. 1 schematically illustrates ome of the mito- 
chondrial processes that may respond to changes in matrix 
Ca 2+ concentrations. McCormack and Denton and their 
coworkers [6-8] identified three CaZ+-regulated intramito- 
chondrial dehydrogenases, namely pyruvate dehydrogenase 
(mediated through the Ca2+-sensitive PDH phosphatase), 
c~-ketoglutarate d hydrogenase and NAD-linked isocitrate 
dehydrogenase. Together, the Ca2+-dependent changes in 
activity of these enzymes can account in large part for the 
changes in citric acid cycle flux occurring in response to 
hormonal stimulation i  heart, liver and other tissues [6-9]. 
In addition, there is evidence for Ca2+-dependent control 
of ATP synthase activity possibly mediated through the 
ATPase inhibitor protein [10,11 ]. Halestrap and coworkers 
[12] demonstrated that mitochondrial pyrophosphatase i  
inhibited by Ca 2÷ and proposed that this enzyme indirectly 
affects mitochondrial volume control and electron trans- 
port flux. Ca 2÷ has also been proposed as a regulator of 
adenine nucleotide translocator function [13], although a 
specific Ca2+-sensitive mechanism for this process has not 
been identified. Finally, the mitochondrial Ca 2+ level is a 
critical element in the mitochondrial permeability transi- 
tion (MPT), a process that appears to involve the assembly 
of a high conductance proteinaceous pore across the inner 
and outer membrane and that is characteristically inhibited 
by the immunophilin cyclosporin A (CyA) [14]. The pro- 
tein components involved in this permeability transition 
remain poorly characterized. There is good evidence to 
suggest an involvement of the adenine nucleotide translo- 
cator [15,16] and the outer membrane porin (VDAC) in 
this process [17]. However, no obvious CaZ+-dependent 
protein has been identified as being involved in the MPT. 
Until recently, the MPT had been studied primarily in 
isolated mitochondrial preparations under conditions of 
excessive Ca 2+ loading and the physiological relevance of 
this process, or even its occurrence in intact cells and 
tissues remained a matter of conjecture. However, two 
lines of investigation have converged to place the perme- 
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Fig. 1. Schematic diagram of cellular Ca 2+ homeostasis showing postulated mitochondria] sites of action of Ca 2+ (modified from [9]). 
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ability transition in the center of the debate about mecha- 
nisms of cell injury. Firstly, a variety of studies on isolated 
mitochondria have helped characterize the factors that 
control the permeability transition [14-20]. Notably, 
Bernardi [18] demonstrated that mitochondrial depolariza- 
tion can promote the permeability transition even in the 
absence of excessive Ca 2+ loading. Parallel electrophysio- 
logical studies further characterized a Ca2+-dependence of 
the voltage sensitivity of the opening of the non-selective 
pore that is characteristic of the MPT [20]. Secondly, the 
characteristic sensitivity of the MPT to CyA [20-22] has 
provided a tool to study the occurrence of the MPT in 
intact cells and tissues and its involvement in cellular 
events associated with cell injury. 
1.2. Relationship between cytosolic and mitochondrial 
Ca 2 + concentrations 
Despite extensive studies on Ca 2+ transport processes 
in isolated mitochondria (reviewed in [6,7,14]), the regula- 
tion of Ca 2+ transport across the mitochondrial membrane 
in intact cells is still poorly understood and it is not yet 
clear how an oscillatory Ca 2+ elevation in the cytosol 
would raise matrix Ca 2+ levels. Ca 2+ is accumulated in
energized mitochondria through the Ca 2+ uniporter, driven 
by the membrane potential, i.e., down the electrochemical 
gradient of Ca 2+. Efflux from the matrix occurs through 
rather less well characterized pathways, one of which is 
generally described as a Ca2+/Na + exchange process, 
another (which predominates in liver) may involve 
CaZ+/H + exchange. Both of these effiux pathways are 
presumed to saturate at relatively low matrix Ca 2+ levels 
[14,23]. In addition, the permeability transition pore is a 
non-selective effiux pathway through which Ca 2+ can be 
released after reaching a threshold concentration of Ca 2+ 
in the matrix [14]. The Ca 2+ uniporter has a marked 
sigmoidal [Ca 2+ ] dependence with a K0. 5 of 5-10 /zM at 
prevailing cytosolic Mg 2+ levels [14]. Hence, at resting 
levels of [Ca ~-+ ]cyt uptake is minimal and there is good 
evidence now that matrix Ca 2+ concentrations in intact, 
unstimulated cells are not significantly elevated over those 
in the cytosol [6,7,14,24,25]. 
An increase in [Ca~-+]cy t to the levels observed in 
stimulated cells (0.5-2 /zM), whether induced by a hor- 
mone or by other agents that promote Ca 2+ release from 
intracellular stores or Ca 2+ flux across the plasma mem- 
brane, would enhance the rate of Ca 2+ uptake into the 
mitochondria. However, due to the sigmoidal dose-re- 
sponse relationship, Ca 2+ influx should be disproportion- 
ally high at the peak of the Ca 2+ elevation. The total 
amount of Ca 2+ taken up during a transient [CaZ+]cyt 
elevation also depends on the time of exposure to elevated 
Ca 2+ levels and may be further influenced by local subcei- 
lular gradients of [Ca 2+ ]~yt. For instance, a recent paper by 
Rizutto et al. [26] using mitochondrially targeted aequorin 
analogs reported that a high local concentration of Ca 2+ 
may be detected by mitochondria in the vicinity of Ca 2+ 
release channels in the ER during stimulation with InsP 3. 
Furthermore, the recovery of basal matrix Ca 2+ levels 
after the decay of a [Ca 2+ ]cyt peak will depend on the time 
lapse between subsequent peaks and the Ca 2+ effiux activ- 
ity. In agreement with the relatively low activity of mito- 
chondrial Ca 2+ effiux processes, Rizutto et al. [26] found 
that the recovery of basal mitochondrial Ca 2+ levels lags 
behind the decay of the cytosolic Ca 2+ peak in intact cells. 
Hence, mitochondrial Ca 2+ uptake during an oscillatory 
Ca ~+ response after hormonal stimulation is expected to 
be affected strongly by the frequency of oscillations. Con- 
sistent with these expectations, modeling studies in heart 
and liver [9,27] indicate that the steady state mitochondrial 
free Ca 2+ level could increase dramatically over a time 
scale of minutes in response to oscillations in [Ca2+]cy t, 
with an increased oscillation frequency translating into 
elevated mitochondrial steady state Ca 2+ levels, even 
though individual Ca 2+ spikes in the cytosol are essen- 
tially unaffected by the hormone dose. This picture was 
confirmed experimentally in elegant studies by Miyata et 
al. [24], who selectively detected compartmentalized in o 
1 in isolated myocytes. Oscillations in mitochondrial Ca 2+ 
content were also detected as changes in mitochondrial 
NAD(P)H and FADH 2 levels in recent studies on vaso- 
pressin-stimulated hepatocytes by single cell fluorescence 
imaging (Hajnoczky, G., Robb-Gaspers, L. and Thomas, 
A.P., unpublished observations). These intramitochondrial 
oscillations were characterized by a delayed decay phase 
compared to the cytosolic Ca 2+ changes. When cytosolic 
Ca 2+ levels are elevated in a sustained fashion, as can be 
done in hepatocytes by enhancing vasopressin-induced 
Ca 2+ release with glucagon (or other agents that activate 
protein kinase A) or by inhibiting the ER Ca 2 + pump with 
thapsigargin, a further elevation of the steady state mito- 
chondrial Ca 2+ level would be expected, reflecting the 
increased aggregate time of exposure of the mitochondria 
to peak [Ca 2 + ]cyt. 
1.3. Ca 2 +-dependent cell injury: the role of the mitochon- 
drial permeabili~ transition 
Although the role of Ca 2+ in metabolic regulation is 
well-established, there is also good evidence that an eleva- 
tion of cellular Ca 2+ levels can be harmful to the cell. For 
instance, in many tissues, reintroduction of Ca 2+ after 
perfusion with Ca 2 +-free medium causes cell damage (the 
'Ca 2+ paradox' [28]). In hepatocytes and other cells, high 
concentrations of extracellular ATP are cytotoxic by caus- 
ing Ca 2+ influx after binding to purinergic P2Y receptors 
[29]. Similarly, Ca 2+ ionophores can induce cell injury in 
a Ca2+-dependent fashion in liver cells and other cell types 
[30]. The mechanism(s) involved in Ca~-+-induced cell 
injury are not yet well characterized. However, there is 
evidence that mitochondria play a critical role in this 
process [14,29,31]. It has been suggested that this reflects 
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the depletion of mitochondrial energy due to cycling of 
Ca 2+ across the mitochondrial membrane [31,32]. How- 
ever, recent evidence from our group [33] suggests that 
mitochondrial deenergization may not itself be responsible 
for short-term cell injury, but the opening of the permeabil- 
ity transition pore in the mitochondrial membrane may 
promote Ca2+-dependent cell injury more directly. Studies 
on cultured hepatocytes demonstrated that deenergization 
of the cells by anoxia or electron transport inhibitors 
caused cell injury only if it was accompanied by a perme- 
ability transition. Agents that suppressed the MPT (e.g., 
CyA) were protective against anoxic cell death, even 
though they did not prevent mitochondrial depolarization 
and the loss of cellular ATP. In more recent studies, 
Pastorino et al. [34] found that depletion of Ca 2+ pre- 
vented the permeability transition and protected liver cells 
against anoxic cell death, despite mitochondrial depolariza- 
tion and cellular ATP depletion. These and other studies 
provide strong evidence that the CaZ+-dependent perme- 
ability transition rather than mitochondrial deenergization 
perse is a critical step that triggers cell injury. 
If the MPT is potentially lethal to intact cells, the 
question arises to what extent accumulation of Ca 2+ in the 
mitochondria can potentiate this process and make cells 
susceptible to agents that cause cell injury. Would the 
mitochondrial Ca 2+ uptake that is associated with hor- 
monal stimulation (or other conditions that increase 
[ Ca2+ ]cyt) be sufficient o potentiate the permeability tran- 
sition, with possible consequences for cell injury? In order 
to investigate these questions, we have exposed liver cells 
to various stimuli, followed by permeabilization a d analy- 
sis of the susceptibility of the mitochondria to undergo the 
permeability transition. In parallel studies, we analyze the 
changes in mitochondrial Ca 2+ content determined under 
the same conditions. 
2. Materials and methods 
2.1. Cell preparation and incubation conditions 
each of leupeptin, pepstatin and aprotinin. Of the original 
suspension medium, 100 /zl was left behind and mixed 
with the BAPTA-containing medium to give a final Ca 2 + 
concentration of 100-150 nM (mean 130 riM), as deter- 
mined in separate incubations to which indo 1 (10 /xM) 
was added. The cell suspension was transferred to a cu- 
vette in a MPF-44B Perkin Elmer spectrofluorometer fo
measuring light scattering changes or Ca 2+ release. The 
fluorometer chamber was provided with temperature con- 
trol and stirring and gassed with 95% COJ5% 0 2. 
2.2. Cell permeabilization and swelling analysis 
Permeabilization of the cells was initiated by addition 
of digitonin (10 /zg/ml), a concentration that was suffi- 
cient to make > 95% of the cells permeable to trypan blue 
within 2-3 min. Light scattering changes were recorded in 
the fluorometer at a wavelength pair of 550 nm/565 nm. 
Digitonin treatment caused a slow increase in light scatter- 
ing (recorded as an increase in apparent fluorescence) over 
a period of 3-5 min which was not markedly affected by 
CyA or changes in incubation conditions. Swelling was 
initiated by the addition of CaC12 or PhAsO and respira- 
tory inhibitors, as indicated. Maximal swelling was deter- 
mined by the addition of an excess CaCI 2 or PhAsO. 
2.3. Determination of  mitochondrial Ca: + content 
Cell were resuspended in the BAPTA-containing 
medium in the fluorometer cuvette. Indo 1 (10 /xM) was 
added to the medium and fluorescence was measured at a 
wavelength pair of 340 nm/395 nm. Ca 2+ release was 
measured as an increase in indo 1 fluorescence and cali- 
brated after each incubation by the addition of small 
amounts of a standard CaC12 solution. Where indicated, 
the free Ca 2+ concentration i the solution was estimated 
by adding excess CaCI 2 and excess EGTA to determine 
maximum and minimum fluorescence intensities, using a 
K d for indo 1 Ca 2+ binding of 250 nM. 
Hepatocytes were isolated from male Sprague-Dawley 
rats by collagenase perfusion as previously described [35] 
and stored on ice until use. Incubations were carried out in 
capped plastic containers in a 37 ° C shaking water bath in 
a modified Krebs-Ringer bicarbonate buffer containing 
127 mM NaC1, 25 mM NaHCO 3, 4 mM KC1, 1 mM 
MgCI 2, 1.2 mM K-Pi, 2 mM CaC12, 10 mM Hepes (pH 
7.4), and 1.8% BSA, under a gas phase of 95% 02/5% 
CO 2, at a cell concentration of 5 mg protein/ml, in a final 
volume of 2.5 ml. Additions of hormones or other agonists 
were made as indicated. Just prior to permeabilization, the 
cells were washed and resuspended in 2.5 ml of a medium 
containing 120 mM KCI, 25 mM NaHCO 3, 0.5 mM 
MgC12, 3 mM K-Pi, 10 mM DL-3-hydroxybutyrate, 20 mM 
Hepes (pH 7.4), 1 mM BAPTA (free acid), and 1 /zg/ml 
3. Results 
3.1. Mitochondrial swelling in permeabilized hepatocytes 
The large amplitude swelling that accompanies the MPT 
has been commonly identified in suspensions of isolated 
mitochondfia by following changes in light scattering at a 
suitable wavelength [14,18,33]. As shown in Fig. 2, similar 
light scattering changes (measured in these experiments by 
following the 90 ° light scattering changes in a fluorometer 
at a wavelength pair of 550/565 nm) are obtained when 
hepatocytes are permeabilized with digitonin and treated 
under conditions that promote the MPT. Prior to permeabi- 
lization, cells were washed in a 'cytosolic' medium (see 
Section 2) containing 1 mM BAPTA and sufficient Ca 2+ 
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Fig. 2. Mitochondrial swelling in permeabilized hepatocytes, (A) Inhibi- 
tion by CyA of Ca:+-induced swelling. (B) Swelling induced by pheny- 
larsenoxide and mitochondrial nhibitors. Cells (5 mg/ml) were sus- 
pended in a BAPTA (1 mM)-buffered medium (free [Ca 2÷ ] 130 nM) as 
described inSection 2. Light scattering changes after addition of digitonin 
(10 /zg/ml) were followed in the fluorometer at a wavelength pair 550 
nm/565 nm (AFss0/565). 
to buffer the final [Ca 2+] at about 130 nM, close to the 
free [Ca R+] in the cytosol of unstimulated cells. /3-Hy- 
droxybutyrate (10 mM) was added as a substrate for 
mitochondrial oxidation that could be used both in intact 
cells and in mitochondria of permeabilized cells. Permeabi- 
lization by digitonin was accompanied by an increase in 
light scattering (increase in apparent fluorescence, AF) ,  
which stabilized after 3-5 min and remained constant for 
at least 20 min in the absence of further additions. Re- 
peated additions of CaC12 (20 /xM, equivalent o approx. 
17 nmol /mg mitochondrial protein) caused a decrease in 
light scattering, indicating mitochondrial swelling (Fig. 
2A). This mitochondrial swelling was initially small and 
transient, but increased markedly and irreversibly after 
three or more additions of Ca 2+. When cells were pre- 
treated with CyA (5 ~M), the Ca2+-induced light scatter- 
ing changes were markedly suppressed and remained tran- 
sient, even after addition of > 200/xM Ca 2÷. This pattern 
of Ca2+-induced, CyA-sensitive light scattering changes in 
a Pi-containing medium is characteristic for the MPT as 
studied in isolated mitochondria [14]. When mitochondrial 
energization and, hence, mitochondrial Ca 2-- uptake was 
inhibited by prior addition of rotenone, Ca 2 + addition did 
not induce light scattering changes (not shown). However, 
as shown by Bemardi [18], deenergized mitochondria re 
susceptible to undergo the permeability transition when 
challenged with a 'trigger agent', such as phenylarsenox- 
ide (PhAsO), even in the absence of added Ca 2~. The 
same phenomenon occurs in digitonin-permeabilized cells, 
as shown in Fig. 2B. PhAsO (40 /xM) had little effect by 
itself in permeabilized cells in the presence of a source of 
energy (/3-hydroxybutyrate), but the addition of rotenone 
induced a marked decrease in light scattering, compatible 
with mitochondrial swelling. The inhibitor itself had liule 
effect and CyA prevented the light scattering induced by 
rotenone in the presence of PhAsO. Thus, the swelling 
characteristics of permeabilized cells were consistently 
similar to those reported for suspensions of isolated mito- 
chondria and indicate that the MPT accounts for these 
effects. 
In further experiments, we studied the effect of pretreat- 
ment of hepatocytes with different agonists on their sus- 
ceptibility to undergo the permeability transition (Fig. 3). 
Cells were incubated with vasopressin, TPA, or thapsigar- 
gin for 15 min in a standard Krebs-Ringer bicarbonate- 
Hepes buffer (see Section 2), containing /3-hydroxy- 
butyrate as a substrate, followed by washing with BAPTA 
medium and permeabilization with digitonin. Subse- 
TPA 
treated . Thaps + TPA 
Vasopressin ~ ~ Th . . . .  Vaso t \  
PhlsO ~ t -"x~ 
I 0 uM ~. PhAsO l 
10 uM Rotenone 
- %  
Fig. 3. Effect of thapsigargin, vasopressin a d TPA pretreatment on 
mitochondrial swelling in permeabilized hepatocytes induced by PhAsO 
and rotenone. Cells were preincubated for 15 rain with 100 nM vaso- 
pressin, 100 nM TPA, or 1 /xM thapsigargin, prior to digitonin permeabi- 
lization. After light scattering changes had stabilized, cells were chal- 
lenged with 10 /xM PhAsO and 4 /zM rotenone. Results are typical of 
4-8 similar experiments. 
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Fig. 4. Effect of thapsigargin and vasopressin pretreatment on mitochon- 
drial Ca 2+ content determined in permeabilized cells. Cells were preincu- 
bated for 15 min with no additions, or with 100 nM vasopressin or 1 ~M 
thapsigargin, prior to digitonin permeabilization i BAPTA-containing 
medium. Indo 1 (10 /zM) was added to measure Ca 2÷ concentrations in 
the medium and CyA (5 ~tM) was present o suppress light scattering 
changes. Rotenone, antimycin and oligomycin (1 p.M each) were added 
to inhibit respiration and ionomycin (20 /zM) was added to initiate Ca 2+ 
release• Ca 2+ release was calibrated with small additions of standard 
Ca 2+ solution and mitochondrial Ca 2+ content was calculated assuming 
that liver cells contain 0.24 mg mitochondrial protein/rag total cell 
protein [37]. Results are typical traces from one experiment, representa- 
tive of 4 -6  similar ones. 
quently, the permeabilized cells were challenged with a 
low concentration of PhAsO (10 /zM), followed by 
rotenone. Under these conditions, control cells underwent 
a slow rate of swelling, which was markedly accelerated in 
cells pretreated with thapsigargin. By contrast, pretreat- 
ment of the cells with a saturating concentration (100 nM) 
of vasopressin slightly decreased the rate of swelling. 
Unexpectedly, vasopressin pretreatment also partly sup- 
pressed the thapsigargin-induced enhancement of 
rotenone-induced swelling. The effects of vasopressin were 
mimicked by treatment with TPA (100 nM), indicating that 
activation of protein kinase C may have been responsible 
for suppressing the rotenone-induced swelling under these 
conditions. In other experiments ( ee below), we found 
that pretreating the cells with glucagon did not signifi- 
cantly affect the rate of rotenone-induced swelling, but 
glucagon greatly enhanced the swelling when added in the 
presence of vasopressin. 
3.2. Effects of hormone treatment on mitochondrial Ca e + 
accumulation i  intact cells 
The role of mitochondrial Ca 2+ loading in altering the 
susceptibility of the mitochondria to undergo the perme- 
ability transition was investigated under similar conditions, 
as illustrated in Fig. 4. Cells were preincubated for 15 min 
in the presence of different agonists and washed with 
BAPTA medium to buffer free Ca 2+ levels at about 130 
nM prior to permeabilization with digitonin. Indo 1 (10 
/zM) was added to the medium and the CaZ+-dependent 
fluorescence was detected at a wavelength pair of 340/395 
nm. CyA (5 #zM) was added to the permeabilized cells to 
suppress light scattering changes that might interfere with 
the determination f Ca 2+-dependent i do 1 fluorescence. 
The Ca 2+ content of intracellular compartments was deter- 
mined by inhibiting mitochondrial energization with a 
mixture of rotenone, antimycin and oligomycin, followed 
by ionomycin (20/zM) to release compartmentalized Ca 2+. 
The Ca e+ release was calibrated in each incubation by the 
o 40 
~ 20 
o 
I + 
tD 
**  + 40 
A 1:" 00 o
Treatment  
Fig. 5. Effect of pretreatment of intact hepatocytes with different agonists on mitochondrial Ca 2+ content (A) and susceptibility to rotenone-induced 
swelling (B) determined in permeabilized hepatocytes. Results obtained from 3-8 experiments carried out as shown in Figs. 3 and 4. Swelling rates were 
quantified by measuring the change in light scattering at 1 minute after addition of rotenone, normalized to the maximal swelling obtained with 40 /zM 
PhAsO. * P < 0.05 and * * P < 0.01, respectively, compared to control; ( + ) P < 0.05 compared to incubations with thapsigargin alone. 
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subsequent addition of known amounts of CaCl 2. Due to 
the Ca 2+ buffering by BAPTA, the change in free [Ca 2+] 
in the medium was minor (< 1% of total indo 1 fluores- 
cence) and fluorescence changes were linear with [Ca 2+ ] 
over the range studied. The mitochondrial inhibitors them- 
selves caused a small increase in fluorescence that was not 
dependent on the presence of cells and was not affected by 
preincubation conditions. Under these conditions, deener- 
gization of the mitochondria does not cause the release of 
Ca 2+ from the mitochondrial matrix, since the reversal of 
the Ca 2+ uniporter is ineffective at low external Ca 2+ 
concentrations [36]. The ionomycin-induced fluorescence 
change was largely due to Ca 2+ released from the mito- 
chondrial compartment, as indicated by the finding that 
thapsigargin addition to permeabilized cells did not cause a 
significant change in CaZ÷-dependent fluorescence (not 
shown). 
When intact cells were preincubated for 15 min with 
either vasopressin (B) or particularly with thapsigargin (C) 
prior to permeabilization, a marked increase in the com- 
partmentalized Ca2+ pool was found, indicating accumula- 
tion of Ca 2+ in the mitochondria during stimulation with 
these agonists. Preincubation of the cells with thapsigargin 
for longer periods than 15 rain caused a corresponding 
further increase in compartmentalized Ca R +, indicating that 
this agent caused a sustained accumulation of Ca 2+ in the 
mitochondria which continued for up to 60 min (not 
shown). This was accompanied by a concomitant increase 
in the susceptibility to undergo the permeability transition 
as detected in parallel swelling assays. 
Fig. 5 gives a summary of the effects of preincubation 
with different agonists on the mitochondrial Ca 2+ content, 
in comparison with their effect on the susceptibility to 
rotenone-induced swelling (determined as the normalized 
rate of swelling induced by rotenone in the presence of 
PhAsO). In control incubations, the compartmentalized 
Ca 2+ was very low, in the order of 0.25-0.5 nmol/mg 
cellular protein, corresponding to 1-2 nmol/mg mito- 
chondrial protein. A 15 minute preincubation of the cells 
with 100 nM vasopressin caused a significant 2-2.5 fold 
increase in the mitochondrial Ca 2+ content, whereas thap- 
sigargin treatment caused a marked additional increase in 
compartmentalized Ca2+, to a level of 4-6 nmol/mg 
cellular protein (corresponding to 17-25 nmol/mg mito- 
chondrial protein). Hence, the large increase in rotenone- 
induced swelling caused by thapsigargin was associated 
with an extensive accumulation of Ca 2+ in the mitochon- 
drial matrix, but the (much smaller) increase in vaso- 
pressin-induced Ca 2+ accumulation did not correlate with 
an enhancement of the permeability transition. Glucagon 
and TPA did not cause a significant alteration in mitochon- 
drial Ca 2+ content. However, glucagon markedly en- 
hanced the mitochondrial Ca 2+ accumulation i duced by 
vasopressin, as reported previously [38,39] and this was 
also associated with a marked increase in the PhAsO + 
rotenone-induced swelling. Vasopressin and TPA had little 
effect on the mitochondrial Ca 2 + accumulation i duced by 
thapsigargin. Hence, the partial inhibition by these agents 
of thapsigargin-induced mitochondrial swelling is not 
caused by preventing the accumulation of Ca 2+ into the 
mitochondria, but appears to suppress the mitochondrial 
susceptibility to undergo the permeability transition even 
at excessive Ca 2+ loading. By contrast, glucagon further 
enhanced thapsigargin-induced Ca 2+ uptake, although this 
had no consistent effect on the (already high) rate of 
swelling. 
4. Discussion 
4.1. Mitochondrial Ca 2 + uptake under different conditions 
of cellular stimulation 
Although previous tudies have provided strong indica- 
tions that mitochondria take up Ca 2+ in response to a 
hormonally induced elevation of [Ca 2+ ]~y~ in intact hepato- 
cytes, factors that control this Ca 2+ uptake have not been 
well characterized. The approach used here of determining 
mitochondrial Ca 2+ content in permeabilized cells after 
stimulation of intact cells, relies on the capacity of mito- 
chondria to retain accumulated Ca 2+ when exposed to a 
medium of low Ca 2+. The reasons for this Ca 2+ retention 
are not well characterized. It is not due solely to the 
membrane potential-driven Ca 2+ uptake through the uni- 
porter matching an efflux of Ca 2+, since deenergization f 
the mitochondria with respiratory inhibitors did not pro- 
mote a rapid effiux of Ca 2+, even under conditions where 
Ca 2+ accumulation was very high (Fig. 4). Probably, the 
Ca 2+ uniporter is inhibited at the low free [Ca 2+] in the 
presence of Mg 2+ in the BAPTA-containing medium, as 
reported by Igbavboa and Pfeiffer [36]. However, this 
would not explain why Ca 2+ efflux on other Ca 2+ trans- 
port systems would be inhibited. Also, the fact that iono- 
mycin could rapidly activate Ca 2+ efflux from the mito- 
chondria in the permeabilized cells indicates that the Ca 2+ 
retention was not caused by a slow equilibration between 
free and bound Ca 2+ in the matrix, but was due to a 
limitation in the transmembrane Ca2. flux. 
Although ionomycin also releases Ca 2+ from other 
compartments than mitochondria, these stores appeared to 
contribute little to the total compartmentalized Ca 2+. This 
was indicated by the observation (not shown) that the 
addition of thapsigargin in permeabilized cells did not 
induce a significant Ca 2+ release. Also, the large amount 
of Ca 2+ accumulated when intact cells were incubated 
with thapsigargin or with vasopressin + glucagon can only 
be accounted for by mitochondrial Ca 2+ uptake, since the 
mitochondrial capacity for Ca 2+ accumulation well ex- 
ceeds that of the ER Ca -,+ stores. The ER Ca 2+ stores are 
probably largely released during permeabilization with 
digitonin; Ca 2~ reuptake into the ER would be limited in 
the absence of ATP, nor would Ca 2+ be available for 
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uptake by the mitochondria due to the rapid buffering 
action of BAPTA. Thus, it is also unlikely that the mito- 
chondrial Ca 2+ content was artificially increased after 
permeabilization by the uptake of Ca 2+ released from 
other Ca 2 + stores. 
A mitochondrial Ca 2+ content of 1-2 nmol/mg mito- 
chondrial protein (mean of 1.6 +_ 0.2 nmol /mg in 8 exper- 
iments) was detected in untreated hepatocytes. This is 
equivalent o the Ca 2+ content found in isolated liver 
mitochondria obtained under conditions that strictly ex- 
clude Ca 2+ uptake during isolation and would correspond 
to a free matrix Ca 2+ concentration of 100-200 nM 
[8,23,39]. Rizutto et al. [25,26] using mitochondrially tar- 
geted aequorin analogs reported matrix free Ca 2+ concen- 
trations of about 200 nM in unstimulated cells. These 
findings further indicate that the mitochondrial Ca 2+ con- 
tent obtained in control incubations faithfully represented 
the state of mitochondria in control hepatocytes. 
Stimulation of the cells with thapsigargin or vaso- 
pressin, agents that are known to increase [Ca 2+ ]~yt, signif- 
icantly increased mitochondrial Ca 2+ accumulation. How- 
ever, the pattern of Ca 2+ uptake with these two stimuli 
was markedly different. Mitochondrial Ca 2+ increased 
rapidly after stimulation with vasopressin to a level of 
3.1 _+ 0.2 nmol /mg (n = 6). In other experiments (not 
shown), we found that this Ca 2+ level was reached already 
after a few minutes stimulation and remained constant 
during subsequent incubations with hormone for at least 30 
min. When glucagon was also present, rapid Ca 2+ uptake 
continued for about 15 min and declined afterwards. By 
contrast, thapsigargin-treated c lls showed a sustained in- 
crease in the mitochondrial Ca 2+ level that continued for 
up to 60 min and induced an accumulation of >40 
nmol/mg. The origin of these different accumulation pat- 
terns is not clear. At the high level of vasopressin used in 
these experiments (100 nM) Ca 2+ stores are maximally 
released and [Ca 2+ ]~yt is elevated to a similar level as that 
obtained with thapsigargin, (approx. 0.5-2 /~M). Hence, 
the different patterns of Ca 2+ accumulation must be caused 
by effects of these agents at the level of mitochondrial 
Ca 2+ handling. Since the combination of vasopressin and 
thapsigargin also showed a continued mitochondrial Ca 2 + 
accumulation pattern, this effect may be caused by thapsi- 
gargin acting on the mitochondrial Ca 2+ transport systems, 
either promoting Ca 2+ uniporter activity, or inhibiting a 
Ca 2+ effiux pathway. The net result is that the rate of 
mitochondrial Ca 2+ uptake exceeds the maximal activity 
of the effiux pathway, resulting in a sustained net Ca 2+ 
accumulation i  the matrix at a rate of 1-1.5 nmol/min 
per mg. Experiments are currently under way to identify 
the nature of this effect of thapsigargin. 
Other agonists (glucagon, TPA) had no significant ef- 
fect on basal mitocbondrial Ca 2+ levels. However, 
glucagon significantly increased mitochondrial Ca 2 + accu- 
mulation in vasopressin-stimulated cells, in agreement with 
earlier reports [38]. This effect of glucagon occurred even 
with a saturating vasopressin concentration (100 nM), that 
maximally releases ER Ca 2+ stores and causes a sustained 
elevation in [Ca 2+ ]cyt. This makes it unlikely that glucagon 
exerts this effect by potentiating InsP3-induced Ca 2+ re- 
lease at the level of the InsP 3 receptor, a known site of 
action of protein kinase A [40-42]. Instead, glucagon may 
act by inhibiting Ca 2+ effiux from the cell at the level of 
the plasma membrane Ca 2+ pump [43], which could fur- 
ther elevate [Ca 2+ ]cyt, or glucagon could affect mitochon- 
drial Ca 2+ transport itself, either directly, or through its 
effect on the cellular Mg 2+ distribution [44]. It is of 
interest hat glucagon also caused an increase in the mito- 
chondrial Ca 2+ uptake induced by thapsigargin, suggesting 
that these two agents acted by different mechanisms. 
In summary, different agonists that elevate [CaZ+]cyt 
induce mitochondrial Ca 2+ uptake in intact cells, but the 
pattern of Ca 2+ accumulation i  the mitochondrial com- 
partment is markedly different from one agonist o another, 
probably owing to factors that modulate the characteristics 
of Ca 2 + transport systems in the mitochondrial membrane 
or elsewhere in the cell. 
4.2. Correlation between mitochondrial Ca 2 + uptake and 
the mitochondrial permeability transition 
Digitonin-permeabilized hepatocytes appeared to be 
susceptible to large amplitude CaZ+-induced swelling with 
characteristics that were very similar to those used tradi- 
tionally to study the MPT in isolated mitochondria [14,18]. 
Hence, this approach could be applied to analyze changes 
in the susceptibility to MPT pore opening in response to 
different reatments in intact cells. In the present studies, 
the MPT was triggered by treating the cells with a low 
concentration of PhAsO and determining the swelling in- 
duced by addition of rotenone [18,33]. The advantage of 
this approach is that the susceptibility of the mitochondria 
to undergo the MPT can be studied in the absence of 
additional Ca 2+ loading, which enabled us to analyze the 
consequences of mitochondrial Ca 2+ accumulation i  re- 
sponse to external stimuli. 
The sustained mitochondrial Ca 2+ uptake induced by 
thapsigargin i intact hepatocytes resulted in mitocbondria 
being much more susceptible to undergo the permeability 
transition. The magnitude of the large amplitude swelling 
was generally correlated with the amount of Ca 2+ taken up 
in the mitochondrial compartment, in agreement with the 
expectation that the MPT would be potentiated by mito- 
chondrial Ca 2+ accumulation. However, the effects of 
hormone treatment did not readily match this simple pat- 
tern. Despite causing a two-fold increase in mitochondrial 
Ca 2+ content, vasopressin treatment did not potentiate the 
MPT, but instead suppressed the swelling. Although mito- 
chondrial swelling was enhanced by the marked further 
Ca 2+ accumulation occurring when cells were incubated 
with the combination of vasopressin and glucagon, the rate 
of swelling was less than with thapsigargin-treated c lls 
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which had accumulated similar amounts of mitochondrial 
Ca 2+. Moreover, when vasopressin was included in the 
incubations with thapsigargin, the mitochondria were less 
susceptible to the permeability transition, although the 
Ca 2+ accumulation in the mitochondria was almost the 
same. Similarly, TPA pretreatment partly suppressed the 
MPT in permeabilized cells, even when added in combina- 
tion with thapsigargin, although it did not affect the mito- 
chondrial Ca 2+ accumulation. These findings suggest hat 
mitochondrial Ca 2+ accumulation is only one of the pa- 
rameters that determine the sensitivity of the mitochondria 
to the MPT-activating factors. The similarity of the effects 
of vasopressin and TPA in these experiments indicate an 
involvement of protein kinase C. The mechanism underly- 
ing this effect has not yet been identified, but may be 
related to the protective ffects of protein kinase C activa- 
tion on the mitochondrial Mg depletion reported by Ro- 
mano et al. [45]. Isolated mitochondria can be protected 
against he MPT by increasing their Mg 2+ content, proba- 
bly because Mg 2+ shifts the affinity for Ca 2+ of critical 
binding sites involved in the MPT [19]. By contrast, 
glucagon or cAMP analogs have been reported to promote 
Mg 2 + release from mitochondria [44]. Whatever the mech- 
anism, these findings illustrate the point that hormones 
may affect mitochondrial characteristics by other mecha- 
nisms than by inducing Ca 2+ accumulation. Further stud- 
ies are required to investigate the nature of these effects of 
vasopressin and TPA. 
4.3. Re lecance. for  cell  injur3, 
Although the Ca2+-induced mitochondrial swelling now 
known as the MPT has been extensively studied in isolated 
mitochondria [14-22], its physiological significance and 
even its occurrence in intact cells have long been issues of 
debate. Recently, however, the use of CyA, which several 
groups identified as an inhibitor of the permeability transi- 
tion pore [20-22], has provided evidence that the MPT 
occurs in intact hepatocytes and other cells, often under 
conditions associated with irreversible cell injury 
[33,34,46-48]. Studies by Farber and associates [33] 
demonstrated that exposure of liver cells to prolonged 
anoxia or treatment with inhibitors of electron transport is 
associated with an increased permeability of the mitochon- 
drial membrane to [3H]sucrose that precedes cell killing. 
Treatment with CyA protected against cell killing and 
prevented mitochondrial permeabilization, but had no ef- 
fect on the mitochondrial depolarization and the loss of 
ATP caused by the inhibition of electron transport [33,34]. 
Both the cell killing and the mitochondrial permeabiliza- 
tion could also be prevented by Ca 2+ depletion prior to 
treatment with respiratory inhibitors or anoxic conditions 
[34]. These data argue strongly that the Ca: +-dependent 
opening of a large-conductance pore in the mitochondrial 
membrane is a critical step in the sequence of events 
leading to cell death under conditions of cellular anoxia. 
Similarly, other authors have observed a protective ffect 
of CyA on cell killing by agents that cause oxidative stress 
or Ca 2+ overload, or associated with reperfusion injury, 
indicating that the MPT is involved in these events [46-48]. 
However, in these studies it is often difficult to determine 
unequivocally whether the cell killing is the consequence 
of the MPT itself or is brought about by a cellular deener- 
gization that is secondary to the MPT. 
The data presented in this paper indicate that a sus- 
tained elevation of [Ca2+]cytcan lead to the accumulation 
of Ca 2+ in the mitochondrial matrix and thereby promote 
the induction of the MPT as determined in permeabilized 
cells. It is to be expected that these treatments also en- 
hance the susceptibility to MPT induction in intact cells 
and thereby increase the cell's sensitivity to injury by 
anoxia or certain other challenges. This hypothesis is 
currently under investigation. However, in our experiments 
the mitochondrial Ca 2+ accumulation appeared to be in- 
sufficient by itself to induce the MPT in intact cells, even 
when as much as 30-40 nmol Ca2+/mg mitochondrial 
protein was accumulated. This observation illustrates not 
only the marked Ca 2+ uptake capacity of mitochondria in
intact cells, but also demonstrates that other triggers be- 
sides Ca 2 + accumulation are required for mitochondria to 
undergo the MPT. In liver cells exposed to anoxic condi- 
tions both the mitochondrial depolarization and the accu- 
mulation of long chain acylCoA esters promote the MPT 
[33]. Our data also indicate that treatment with vasopressin 
or TPA further protects mitochondria gainst the MPT. 
Neither of these agents significantly decreased thapsigar- 
gin-induced Ca 2+ accumulation and vasopressin itself in- 
creased basal mitochondrial Ca z* levels in the cells. Thus, 
it is likely that this protection is exerted by diminishing the 
potentiating effects of other trigger conditions that activate 
the MPT. 
Physiologically, it is interesting that the two signalling 
branches of a phosholipase C-activating hormone, such as 
vasopressin, appear to have compensating effects on condi- 
tions that affect the MPT. This may serve as a device to 
prevent inappropriate opening of the permeability transi- 
tion pore under conditions where the metabolic effects of 
the hormone rely at least in part on the accumulation of 
Ca 2+ in the mitochondria. On the other hand, if the 
permeability transition is a component of normal cellular 
physiology, it is imperative for the cell to have methods to 
carefully control the conditions under which this response 
is activated. The characterization f how the mitochondrial 
effects of these and other hormones are integrated in the 
cellular response to normal and abnormal metabolic stress 
situations remains a challenge for future studies. 
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